These benefits, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the strategy of focusing on ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-related Issues. A investigation review released in https://damienq468uqh5.wikicorrespondence.com/user